Turalio 125MG, 120CT

Ended Awarded Last action

Contract number
15B50526F00000182
Awardee
Awarding agency
Obligated
$22,725

Award facts

Contract value 100% obligated
$22,725.09 Current and potential, with all options
Completion date
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Q517 Pharmacy Services
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Basking Ridge, Bernards, NJ, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on August 31, 2026, for TURALIO 125MG (pexidartinib), a specialty pharmaceutical indicated for treatment of tenosynovial giant cell tumor, under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB).

Place of performance is Basking Ridge, Bernards, NJ. The order carries a firm fixed price structure with an ultimate completion date of August 31, 2026. The delivery order was issued under no set-aside.

Quick answers

Who was awarded contract 15B50526F00000182?

15B50526F00000182 was awarded to Daiichi Sankyo, Inc. by Federal Medical Center Carswell (Correctional Facilities) on August 31, 2026.

How much is contract 15B50526F00000182 worth?

The government has obligated $22,725 on 15B50526F00000182.

Is contract 15B50526F00000182 an order under another contract?

Yes. 15B50526F00000182 is a delivery order under 36F79718D0403, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 15B50526F00000182 competed?

The extent of competition for 15B50526F00000182 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login